Akebia Therapeutics, Inc. (AKBA) SEC Filings — 2025
15 SEC filings for Akebia Therapeutics, Inc. (AKBA) in 2025.
Filings
- Akebia Therapeutics Files 8-K: Material Agreement, FD Disclosure — 8-K · Dec 1, 2025
- Akebia Therapeutics, Inc. 8-K Filing — 8-K · Nov 17, 2025
- Akebia's Cash Surges Amidst Auryxia Generic Threat — 10-Q · Nov 10, 2025
- Akebia Therapeutics Files 8-K — 8-K · Oct 28, 2025
- Akebia's Auryxia Drives Strong Q2 Revenue Growth — 10-Q · Aug 7, 2025
- Akebia Therapeutics Files 8-K on Financials — 8-K · Aug 7, 2025
- Akebia Therapeutics Reports Director/Officer Changes & Shareholder Votes — 8-K · Jun 13, 2025
- Akebia Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Akebia Therapeutics Files 8-K — 8-K · May 8, 2025
- Akebia Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
- Akebia Therapeutics Files 8-K: Material Agreement, Other Events — 8-K · Mar 20, 2025
- Akebia Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Akebia Therapeutics Files 8-K on Financials — 8-K · Mar 13, 2025
- Akebia Therapeutics Enters Material Agreement, Reports Equity Sales — 8-K · Feb 7, 2025
- Akebia Therapeutics Files 8-K — 8-K · Jan 13, 2025